EGCG can reduce Ser307 phosphorylation of IRS-1 to attenuate insulin signaling blockade through 5’-AMP-activated protein kinase (AMPK) activation pathway, eventually leading to reduction of insulin resistance [79,80]. This evidence concerns the gene INS and Insulin resistance.